{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Untargeted Bottom-Up Proteomics 实验流程笔记\n",
    "\n",
    "## 实验总览 | Workflow Overview\n",
    "\n",
    "本流程基于 label-free bottom-up proteomics 和 data-dependent acquisition (DDA)，用于大规模蛋白质鉴定和定量。  \n",
    "This workflow uses label-free bottom-up proteomics with data-dependent acquisition (DDA) to identify and quantify proteins from complex samples.\n",
    "\n",
    "---\n",
    "\n",
    "## 1. 样品准备 | Sample Preparation\n",
    "\n",
    "1. 细胞裂解 / 组织匀浆：提取总蛋白  \n",
    "   Cell lysis / tissue homogenization: Extract total protein \n",
    "\n",
    "2. 蛋白定量：常用 BCA 法  \n",
    "   Protein quantification: BCA assay is commonly used  \n",
    "\n",
    "3. 蛋白变性：使用尿素 / 去污剂展开结构  \n",
    "   Denaturation: Use urea or detergents to unfold protein structures  \n",
    "\n",
    "4. 还原与烷基化：断开二硫键并封闭巯基  \n",
    "   Reduction and alkylation: Break disulfide bonds (DTT/TCEP) and block thiols (IAA)  \n",
    "\n",
    "5. 酶解：用 trypsin/LysC 消化生成肽段  \n",
    "   Proteolysis: Digest proteins into peptides using trypsin and LysC  \n",
    "\n",
    "6. 去除杂质 / 清洗：固相萃取去除盐和变性剂  \n",
    "   Cleanup: Solid-phase extraction (SPE) removes salts and denaturants  \n",
    "\n",
    "7. 重溶肽段：使用 LC-MS 兼容缓冲液重溶  \n",
    "   Peptide resuspension: Use LC-MS compatible solvent (e.g., 0.1% FA)  \n",
    "\n",
    "---\n",
    "\n",
    "## 2. LC-MS/MS 分析 | LC-MS/MS Analysis\n",
    "\n",
    "- 液相色谱分离：根据疏水性分离肽段  \n",
    "  Liquid chromatography (LC): Separates peptides based on hydrophobicity  \n",
    "\n",
    "- 电喷雾电离（ESI）：将肽段带电  \n",
    "  Electrospray ionization (ESI): Ionizes peptides from liquid to gas phase  \n",
    "\n",
    "- MS1 扫描：记录所有前体离子（m/z 和强度）  \n",
    "  MS1 scan: Measures precursor ions (m/z and intensity)  \n",
    "\n",
    "- MS2 扫描：选取前体离子碎裂生成碎片谱图  \n",
    "  MS2 scan: Selects and fragments precursors to generate MS/MS spectra  \n",
    "\n",
    "---\n",
    "\n",
    "## 3. DDA 数据采集模式 | Data-Dependent Acquisition\n",
    "\n",
    "- MS1 中选择最强信号的离子进行碎裂  \n",
    "  Top N selection from MS1 for fragmentation  \n",
    "\n",
    "- 使用动态排除防止重复采集  \n",
    "  Dynamic exclusion prevents repeated fragmentation  \n",
    "\n",
    "- 常用碎裂方式为 HCD 或 CID  \n",
    "  HCD or CID are typical fragmentation methods  \n",
    "\n",
    "---\n",
    "\n",
    "## 4. 肽段鉴定 | Peptide Identification\n",
    "\n",
    "- 使用数据库搜索（如 SEQUEST, Andromeda）匹配 MS2 谱图  \n",
    "  Database search tools (e.g., SEQUEST, Andromeda) match MS2 spectra to theoretical peptides  \n",
    "- 设置 FDR 控制假阳性率（常用 1%）  \n",
    "  False Discovery Rate (FDR) is used to control identification quality (typically 1%)  \n",
    "\n",
    "---\n",
    "\n",
    "## 5. 蛋白定量 | Protein Quantification\n",
    "\n",
    "- Label-Free Quantification (LFQ)：使用 MS1 色谱峰面积估算肽段丰度  \n",
    "  LFQ estimates peptide abundance from MS1 chromatographic peak area\n",
    "\n",
    "- 限制：不同肽段间信号不可直接比较  \n",
    "  Limitation: Intensity is peptide-specific and not directly comparable between peptides  \n",
    "\n",
    "---\n",
    "\n",
    "## 6. 蛋白推断 | Protein Inference\n",
    "\n",
    "- 多个肽段整合到蛋白组（protein group）中  \n",
    "  Peptides are assigned to protein groups  \n",
    "- 使用 parsimonious 原则，找出最小蛋白集合解释所有肽段  \n",
    "  Parsimonious inference selects the minimal set of proteins to explain observed peptides  \n",
    "\n",
    "---\n",
    "\n",
    "## 7. 统计分析与功能注释 | Statistical Analysis & Functional Interpretation\n",
    "\n",
    "- 差异分析：使用 Perseus、MSstats、R/Python 工具  \n",
    "  Differential analysis: Tools include Perseus, MSstats, R/Python  \n",
    "- 功能注释：GO 富集、KEGG 通路、STRING 网络  \n",
    "  Biological interpretation: GO enrichment, KEGG pathway, STRING networks  \n",
    "\n",
    "---\n",
    "\n",
    "## 总流程总结 | Final Workflow Summary\n",
    "\n",
    "| 步骤 Step | 中文 | English |\n",
    "|----------|------|---------|\n",
    "| 1 | 裂解 & 变性 | Lysis & Denaturation |\n",
    "| 2 | 还原 & 烷基化 | Reduction & Alkylation |\n",
    "| 3 | 酶解蛋白质 | Protease digestion |\n",
    "| 4 | 去杂质 & 重溶 | Cleanup & Resuspension |\n",
    "| 5 | LC-MS/MS 分析 | LC-MS/MS analysis |\n",
    "| 6 | 谱图搜索与鉴定 | Spectral search & ID |\n",
    "| 7 | 相对定量分析 | Relative quantification |\n",
    "| 8 | 蛋白推断 | Protein inference |\n",
    "| 9 | 功能注释 | Functional interpretation |\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# BCA 蛋白浓度测定法（BCA Assay）\n",
    "\n",
    "## 1. 原理 | Principle\n",
    "\n",
    "BCA assay（Bicinchoninic Acid Assay）是一种用于测定蛋白质浓度的比色分析方法。  \n",
    "The BCA assay is a colorimetric method for determining protein concentration.\n",
    "\n",
    "它基于两步反应：  \n",
    "It involves two sequential reactions:\n",
    "\n",
    "1. **Biuret 反应**（铜还原）| **Biuret Reaction (Cu²⁺ reduction)**  \n",
    "   在碱性条件下，蛋白质将 Cu²⁺ 还原为 Cu⁺  \n",
    "   Proteins reduce Cu²⁺ to Cu⁺ under alkaline conditions.\n",
    "\n",
    "2. **BCA 络合反应** | **BCA-Cu⁺ Complex Formation**  \n",
    "   Cu⁺ 与 BCA（Bicinchoninic Acid）络合生成紫色化合物，在 562 nm 处吸光度最强。  \n",
    "   Cu⁺ reacts with BCA to form a purple-colored complex that absorbs strongly at 562 nm.\n",
    "\n",
    "---\n",
    "\n",
    "## 2. 操作步骤 | Experimental Steps\n",
    "\n",
    "| 步骤 Step | 中文说明 | English Description |\n",
    "|-----------|----------|---------------------|\n",
    "| 1 | 配制 BCA 工作液 | Prepare BCA working reagent |\n",
    "| 2 | 加入蛋白样品（待测） | Add protein sample into wells |\n",
    "| 3 | 加入 BCA 试剂 | Add BCA reagent to each well |\n",
    "| 4 | 孵育（37–60°C，30 分钟） | Incubate at 37–60°C for 30 minutes |\n",
    "| 5 | 读取吸光度（562 nm） | Measure absorbance at 562 nm |\n",
    "| 6 | 根据标准曲线计算浓度 | Calculate protein concentration from standard curve |\n",
    "\n",
    "---\n",
    "\n",
    "## 3. 常用标准品 | Common Standard\n",
    "\n",
    "- **BSA（牛血清白蛋白）** 作为标准品制备标准曲线  \n",
    "  Bovine Serum Albumin (BSA) is used as the standard protein for calibration.\n",
    "\n",
    "---\n",
    "\n",
    "## 4. 优点与注意事项 | Advantages and Considerations\n",
    "\n",
    "| 项目 Item | 中文说明 | English Description |\n",
    "|-----------|----------|---------------------|\n",
    "| 灵敏度 | 检测下限约 0.5 µg/mL | Sensitivity down to ~0.5 µg/mL |\n",
    "| 稳定性 | 紫色产物稳定数小时 | Color product is stable for hours |\n",
    "| 兼容性 | 可容忍多种缓冲液、去污剂 | Tolerates many buffers and detergents |\n",
    "| 干扰物 | DTT、TCEP、EDTA 可能干扰反应 | Reducing agents (DTT, TCEP) and chelators (EDTA) may interfere |\n",
    "\n",
    "---\n",
    "\n",
    "## 5. 参考文献 | References\n",
    "\n",
    "Smith, P. K., et al. (1985). Measurement of protein using bicinchoninic acid. *Analytical Biochemistry*, **150**(1), 76–85.  \n",
    "https://doi.org/10.1016/0003-2697(85)90442-7\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# BCA Assay 原理讲解\n",
    "\n",
    "## 为什么 BCA assay 能测出蛋白质浓度？  \n",
    "**Why can the BCA assay measure protein concentration?**\n",
    "\n",
    "BCA（Bicinchoninic Acid）法测蛋白质，是基于蛋白质**可还原金属离子**这一性质，配合 BCA 显色的化学反应。  \n",
    "The BCA assay is based on the ability of proteins to **reduce copper ions**, combined with the colorimetric detection by BCA.\n",
    "\n",
    "---\n",
    "\n",
    "## 原理分为两步 | Two-Step Mechanism\n",
    "\n",
    "### 1. Biuret 反应：蛋白还原铜 | Biuret Reaction: Protein Reduces Cu²⁺\n",
    "\n",
    "在碱性环境下（通常为碱性缓冲液），蛋白质中的以下结构会将二价铜离子（Cu²⁺）还原为一价铜离子（Cu⁺）：  \n",
    "Under alkaline conditions, proteins reduce Cu²⁺ to Cu⁺ through:\n",
    "\n",
    "- 肽键本身（尤其是两个以上连续肽键）；  \n",
    "  **Peptide bonds**, especially dipeptides or longer chains  \n",
    "- 含硫或芳香氨基酸（如 Cys, Trp, Tyr）  \n",
    "  Amino acid residues like **cysteine, tryptophan, tyrosine**\n",
    "\n",
    "生成的 Cu⁺ 量与蛋白质量成正比。  \n",
    "The amount of Cu⁺ generated is **proportional to the protein content**.\n",
    "\n",
    "---\n",
    "\n",
    "### 2. Cu⁺ 与 BCA 络合显色 | Cu⁺ Forms a Purple Complex with BCA\n",
    "\n",
    "随后，Cu⁺ 与两分子 BCA 形成紫色络合物，在 562 nm 波长具有强吸收：  \n",
    "The Cu⁺ ion forms a **purple complex** with two BCA molecules, which absorbs strongly at **562 nm**.\n",
    "\n",
    "$$\n",
    "\\text{Protein amount} \\propto \\text{Cu}^{+} \\propto \\text{Absorbance}_{562}\n",
    "$$\n",
    "\n",
    "紫色深浅与蛋白质浓度线性相关，可通过标准曲线反推出未知样品浓度。  \n",
    "The intensity of the purple color correlates linearly with protein concentration, allowing quantification via a standard curve.\n",
    "\n",
    "---\n",
    "\n",
    "## 为什么不直接测 Cu⁺？| Why not measure Cu⁺ directly?\n",
    "\n",
    "- Cu⁺ 本身无色，不能直接测吸光度；  \n",
    "  **Cu⁺ is colorless** and does not absorb visible light.  \n",
    "- BCA 与 Cu⁺ 形成的络合物稳定且易检测；  \n",
    "  The **Cu⁺–BCA complex is stable and measurable**.\n",
    "\n",
    "\n",
    "---\n",
    "\n",
    "## 应用说明 | Notes\n",
    "\n",
    "- 常用 BSA（牛血清白蛋白）制作标准曲线；  \n",
    "  **BSA** is used as the standard for calibration.  \n",
    "- 推荐使用空白对照（不含蛋白）扣除背景吸光度。  \n",
    "  A **blank control** is recommended to subtract background absorbance.  \n",
    "- 反应产物稳定，可在数小时内读取。  \n",
    "  The color product is **stable**, allowing flexible reading time.\n",
    "\n",
    "---\n",
    "\n",
    "## 参考文献 | Reference\n",
    "\n",
    "Smith, P. K., et al. (1985). Measurement of protein using bicinchoninic acid.  \n",
    "*Analytical Biochemistry*, 150(1), 76–85.  \n",
    "https://doi.org/10.1016/0003-2697(85)90442-7\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 电喷雾电离（ESI）原理\n",
    "\n",
    "## 什么是 ESI？| What is Electrospray Ionization (ESI)?\n",
    "\n",
    "ESI 是一种将液体样品（如肽段溶液）转化为 **带电气相粒子** 的方法，用于质谱分析。  \n",
    "ESI is a technique that transforms liquid samples (e.g., peptide solutions) into **charged gas-phase ions** for mass spectrometry.\n",
    "\n",
    "---\n",
    "\n",
    "## 原理解释 | Step-by-Step Explanation\n",
    "\n",
    "### 1. 带电液滴喷出 | Charged Droplets Ejected\n",
    "\n",
    "- 肽段溶于水/甲醇等溶液，从一个**细金属喷嘴**喷出；\n",
    "- 喷嘴上加有高压（例如 +3000 V）；\n",
    "- 液滴被电场“充电”，带有多个正电荷（如 H⁺）；\n",
    "\n",
    "Peptide-containing droplets are sprayed from a **metal capillary** under high voltage.  \n",
    "This voltage **charges the droplets**, typically with protons (H⁺).\n",
    "\n",
    "---\n",
    "\n",
    "### 2. 液滴蒸发变小 | Droplet Shrinkage via Evaporation\n",
    "\n",
    "- 带电液滴飞行过程中，**溶剂蒸发**；\n",
    "- 液滴越来越小，但带电量不变；\n",
    "- 电荷密度逐渐升高，电斥力增强。\n",
    "\n",
    "As the solvent evaporates from the droplets, their size decreases while charge remains.  \n",
    "This leads to increased surface charge density and electrostatic repulsion.\n",
    "\n",
    "---\n",
    "\n",
    "### 3. 液滴崩解释放肽段 | Coulomb Explosion and Ion Formation\n",
    "\n",
    "- 当电斥力过大，液滴会崩解；\n",
    "- 肽段以**带电离子形式**喷出（带 1 个或多个 H⁺）；\n",
    "- 这些肽离子进入质谱仪。\n",
    "\n",
    "Eventually, the droplet **breaks apart (Coulomb explosion)** and releases **charged peptides**,  \n",
    "which then **enter the mass spectrometer** as individual ions.\n",
    "\n",
    "---\n",
    "\n",
    "## 比喻理解 | Analogy\n",
    "\n",
    "就像一个装满水的小喷壶，带着电压往外喷，**水蒸发后只剩下被“电场推动”的肽离子**进入 MS 分析。\n",
    "\n",
    "Think of ESI as a charged spray bottle: as the droplets evaporate, only **charged peptide ions** remain and fly into the MS.\n",
    "\n",
    "---\n",
    "\n",
    "## 为什么 ESI 很重要？| Why is ESI Important?\n",
    "\n",
    "- 适用于液体样品，如 LC-MS；\n",
    "- 是一种“温和电离”（soft ionization）方式，不破坏肽段；\n",
    "- 可产生多电荷离子，适合分析高质量分子。\n",
    "\n",
    "ESI is **compatible with liquid chromatography**, gentle enough to **preserve peptide integrity**,  \n",
    "and capable of producing **multiply charged ions**, enabling analysis of large biomolecules.\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## DDA 数据采集模式 | Data-Dependent Acquisition (DDA)\n",
    "\n",
    "DDA 是质谱中最常用的一种 **MS/MS 数据采集方式**，通过对前体离子（MS1）进行选择性碎裂，获得其结构信息（MS2）。  \n",
    "DDA is a common MS/MS data acquisition method that selects precursor ions from MS1 scans for fragmentation and MS2 analysis.\n",
    "\n",
    "---\n",
    "\n",
    "### 什么是 DDA？| What is DDA?\n",
    "\n",
    "- 在每个扫描周期中，质谱仪先进行一次 MS1 扫描，记录所有肽段离子的 m/z 和强度；\n",
    "- 然后从 MS1 图谱中选择**最强的 N 个离子（Top N）**，对它们进行碎裂；\n",
    "- 每个被选中的离子会进入碰撞室（collision cell），生成 MS2 碎片图谱；\n",
    "- 每秒可进行多个 MS1-MS2 扫描循环。\n",
    "\n",
    "In each cycle, the mass spectrometer:\n",
    "\n",
    "1. Performs an MS1 full scan;\n",
    "2. Selects the **top N most intense ions** for fragmentation;\n",
    "3. Acquires their MS2 spectra;\n",
    "4. Repeats this cycle throughout the LC gradient.\n",
    "\n",
    "---\n",
    "\n",
    "### 为什么要动态排除？| What is Dynamic Exclusion?\n",
    "\n",
    "#### 问题：强离子会反复被选中 ➜ 数据浪费  \n",
    "If a strong ion appears repeatedly, it may be selected again and again, wasting MS2 time.\n",
    "\n",
    "#### 解决：动态排除（Dynamic Exclusion）  \n",
    "Once an ion is selected, it is temporarily **excluded** (e.g., for 20 seconds),  \n",
    "so the instrument can focus on **lower-abundance ions**.\n",
    "\n",
    "- 优点：提升检测覆盖率，避免“看重一个离子看到死”；\n",
    "- 设置方式：排除时间（如 20–60 秒）、质量误差范围等。\n",
    "\n",
    "Dynamic exclusion prevents redundant fragmentation of the same precursor,  \n",
    "allowing broader coverage of peptides.\n",
    "\n",
    "---\n",
    "\n",
    "### 常用碎裂方式：HCD vs. CID | Fragmentation Methods: HCD vs. CID\n",
    "\n",
    "| 方法 | 中文名称 | 机制 | 特点 |\n",
    "|------|----------|------|------|\n",
    "| **CID** | 碰撞诱导解离（Collision-Induced Dissociation） | 离子撞击惰性气体（He、N₂），逐步加热断裂 | 常用于离子阱，生成 **b/y 离子** |\n",
    "| **HCD** | 高能碰撞解离（Higher-energy Collisional Dissociation） | 更高能量一次性碰撞打断 | 常用于 Orbitrap，产生清晰 MS2 图谱、适合 TMT 实验 |\n",
    "\n",
    "- CID: Traditional, slow heating, useful for ion trap instruments.\n",
    "- HCD: High-energy, beam-type fragmentation, often used on Orbitraps and TMT workflows.\n",
    "\n",
    "---\n",
    "\n",
    "### 举个例子 | Example (Top 10 + Dynamic Exclusion)\n",
    "\n",
    "- MS1 扫描检测到 1000 个带电肽段；\n",
    "- 仪器选择强度最高的 10 个进行 MS2 碎裂（Top 10）；\n",
    "- 设定“动态排除 30 秒” ➜ 同一个肽段 30 秒内不会再被碎裂；\n",
    "- 下一次扫描选择其余较强的肽段进行分析。\n",
    "\n",
    "---\n",
    "\n",
    "### 总结 | Summary\n",
    "\n",
    "DDA 是一种**基于信号强度选择性采集 MS2 数据**的策略，配合动态排除和合适的碎裂方式（CID/HCD），可有效提高蛋白质组的覆盖率和定性质量。\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# DIA 数据采集模式 | Data-Independent Acquisition (DIA)\n",
    "\n",
    "---\n",
    "\n",
    "## 什么是 DIA？| What is DIA?\n",
    "\n",
    "DIA 是一种不再“挑选前体离子”的数据采集方式，而是把**整个 m/z 范围系统性分段，每段全部碎裂**，记录所有片段信息。  \n",
    "DIA is a data acquisition strategy that **fragments all ions within defined m/z windows**, regardless of their intensity.\n",
    "\n",
    "---\n",
    "\n",
    "## DIA vs DDA 核心区别 | Key Differences: DIA vs. DDA\n",
    "\n",
    "| 特点 | DDA（数据依赖采集） | DIA（数据非依赖采集） |\n",
    "|------|---------------------|------------------------|\n",
    "| 选择方式 | Top N 强度离子 | 所有离子 |\n",
    "| 碎裂方式 | 一个一个碎（有选择） | 分段全部碎裂（无选择） |\n",
    "| 重现性 | 较低（Top N 不稳定） | 高（全段覆盖） |\n",
    "| 数据复杂度 | 简单，谱图干净 | 高度重叠，需要复杂解卷积 |\n",
    "| 常见软件 | MaxQuant, Proteome Discoverer | Spectronaut, DIA-NN, OpenSWATH |\n",
    "| 适用场景 | 鉴定为主 | 定量为主、高通量实验 |\n",
    "\n",
    "---\n",
    "\n",
    "## DIA 工作流程 | How DIA Works\n",
    "\n",
    "1. 将整个 MS1 的 m/z 范围划分为多个小窗口（如 400–1000 分为 20 个 30 m/z 窗）；\n",
    "2. 每一窗口内**所有前体离子同时碎裂**；\n",
    "3. 得到的是**混合 MS2 谱图**，包含多个肽段的碎片信息；\n",
    "4. 用**谱图库（spectral library）**或预测方法进行解卷积分析。\n",
    "\n",
    "---\n",
    "\n",
    "## 举例说明 | Example\n",
    "\n",
    "- m/z 范围：400–1000；\n",
    "- 设置 30 个 DIA 窗口，每个宽 20 m/z；\n",
    "- 扫描顺序为：\n",
    "  - Window 1: 400–420 → 所有离子碎裂；\n",
    "  - Window 2: 420–440 → 所有离子碎裂；\n",
    "  - ...\n",
    "  - Window 30: 980–1000；\n",
    "\n",
    "每个 MS2 谱图都包含多个肽段 → 数据分析需要更高算法支持。\n",
    "\n",
    "---\n",
    "\n",
    "## DIA 的优点 | Advantages of DIA\n",
    "\n",
    "- **无偏性**：不会错过低丰度肽段；\n",
    "- **高度重现性**：不同实验间一致性好；\n",
    "- **适合定量**：可用于大队列、高通量项目；\n",
    "- **兼容谱图库 / AI 预测**：如使用 DIA-NN 或 Prosit。\n",
    "\n",
    "---\n",
    "\n",
    "## DIA 的挑战 | Challenges of DIA\n",
    "\n",
    "- **谱图复杂**：MS2 是混合的，不如 DDA 干净；\n",
    "- **需要专门算法解卷积**；\n",
    "- 依赖高质量谱图库（或深度学习预测）来解释复杂信号。\n",
    "\n",
    "---\n",
    "\n",
    "## 总结 | Summary\n",
    "\n",
    "DIA 提供了一种全面、重复性强的肽段采集方式，适合于**高通量定量研究**。随着 DIA 分析工具（如 DIA-NN、Spectronaut）的发展，DIA 在蛋白质组学中已成为主流定量方法之一。\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# DDA vs. DIA：碎裂方式 & 鉴定 vs. 定量\n",
    "\n",
    "---\n",
    "\n",
    "## 一、碎裂方式对比 | Fragmentation Mode Comparison\n",
    "\n",
    "### DDA（Data-Dependent Acquisition）  \n",
    "**“一个个碎，有选择”**  \n",
    "质谱仪在 MS1 扫描后选出最强的 Top N 个离子，**逐个进行碎裂（MS2）**。  \n",
    "MS2 谱图较干净，但容易漏掉低丰度离子。\n",
    "\n",
    "> 比喻：像老师点名，“你最吵，你上台回答问题”。\n",
    "\n",
    "**DDA selects the top N most intense precursor ions from MS1 and fragments them one-by-one.**  \n",
    "This yields clean MS2 spectra but may miss low-abundance peptides.\n",
    "\n",
    "---\n",
    "\n",
    "### DIA（Data-Independent Acquisition）  \n",
    "**“分段全部碎裂，无选择”**  \n",
    "仪器把整个 m/z 范围分段（如 400–1000 Da），每段内所有离子一起碎裂。  \n",
    "MS2 是混合谱图，后期需要解卷积。\n",
    "\n",
    "> 比喻：像老师按号码段，“1~10号你们一起上来发言”。\n",
    "\n",
    "**DIA fragments all ions within predefined m/z windows simultaneously, creating complex MS2 spectra.**  \n",
    "This provides comprehensive coverage but requires advanced data processing.\n",
    "\n",
    "---\n",
    "\n",
    "## 表格总结 | Comparison Table\n",
    "\n",
    "| 特征 Feature | DDA | DIA |\n",
    "|--------------|-----|-----|\n",
    "| 离子选择 | Top N 强度 | 所有离子（分段） |\n",
    "| MS2 谱图 | 干净，容易解析 | 混合，需解卷 |\n",
    "| 漏检风险 | 高（低丰度肽可能漏掉） | 低（全面采集） |\n",
    "| 数据复杂度 | 低 | 高 |\n",
    "| 适合用途 | 鉴定为主 | 定量为主、高通量分析 |\n",
    "\n",
    "---\n",
    "\n",
    "## 二、鉴定 vs 定量 | Identification vs Quantification\n",
    "\n",
    "### 鉴定（Identification）  \n",
    "> 问题：**“这个碎片是谁？”**  \n",
    "目标是找出每条 MS2 谱图对应的肽段和蛋白。\n",
    "\n",
    "- 靠 MS2 中的 b/y 离子；\n",
    "- 比对数据库；\n",
    "- 输出：蛋白/肽段列表。\n",
    "\n",
    "**Identification asks \"What is this peptide/protein?\" using MS2 spectra and database matching.**\n",
    "\n",
    "---\n",
    "\n",
    "### 定量（Quantification）  \n",
    "> 问题：**“这个蛋白有多少？”**  \n",
    "目标是比较不同样本中相同蛋白/肽段的含量差异。\n",
    "\n",
    "- Label-free ➜ 看 MS1 峰面积；\n",
    "- TMT ➜ 看 reporter ion 强度；\n",
    "- 输出：表达量、差异表达统计。\n",
    "\n",
    "**Quantification asks \"How much of it is present?\" by comparing signal intensities across samples.**\n",
    "\n",
    "---\n",
    "\n",
    "## 对比总结 | Summary Table\n",
    "\n",
    "| 项目 | 鉴定 Identification | 定量 Quantification |\n",
    "|------|---------------------|----------------------|\n",
    "| 意义 | 这是谁？ | 有多少？ |\n",
    "| 数据来源 | MS2 碎片 | MS1 强度或 reporter ion |\n",
    "| 输出 | 蛋白/肽列表 | 表达量/丰度变化 |\n",
    "| 类比 | 谁来了？ | 来了多少人？ |\n",
    "| 关键软件 | 搜索引擎：Andromeda, SEQUEST | 定量软件：MaxQuant, DIA-NN |\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# 肽段鉴定详细解释 | Peptide Identification Explained\n",
    "\n",
    "---\n",
    "\n",
    "## 什么是肽段鉴定？| What is Peptide Identification?\n",
    "\n",
    "目标是：**根据 MS2 谱图，判断这个肽段是谁？**\n",
    "\n",
    "质谱仪不会直接告诉你氨基酸序列，只会给出一组碎片离子的质量（m/z）和强度。  \n",
    "因此我们需要通过 **数据库搜索** 来还原肽段序列。\n",
    "\n",
    "---\n",
    "\n",
    "## 1. 数据库搜索是怎么做的？| How Does Database Searching Work?\n",
    "\n",
    "### 步骤如下：\n",
    "\n",
    "1. 提供一个蛋白质数据库（如 SwissProt）；\n",
    "2. **软件工具**（如 SEQUEST, Andromeda）将数据库中的蛋白质**模拟酶切**生成所有可能的肽段；\n",
    "3. 对每条肽段模拟其理论碎片谱图（b/y 离子）；\n",
    "4. 将实验中获得的 MS2 谱图与这些理论谱图一一比对；\n",
    "5. 计算相似度得分，找出匹配最好的肽段。\n",
    "\n",
    "> 就像“看残片猜原句”：  \n",
    "> MS2 碎片 = 残缺的句子，数据库 = 所有可能的原句，  \n",
    "> 软件负责匹配：哪个原句最可能产生这些残片？\n",
    "\n",
    "---\n",
    "\n",
    "## 2. 什么是 FDR？| What is False Discovery Rate?\n",
    "\n",
    "数据库越大，随机匹配的“伪匹配”就越多。为了不把这些错配当成真结果，我们需要设置统计过滤阈值——这就是 FDR。\n",
    "\n",
    "### FDR 的定义：\n",
    "\n",
    "**在所有被认为是“真实鉴定”的结果中，有多少比例是错误的？**\n",
    "\n",
    "$$\n",
    "\\text{FDR} = \\frac{\\text{False Positives}}{\\text{All Positives}}\n",
    "$$\n",
    "\n",
    "---\n",
    "\n",
    "### 怎么估算 FDR？\n",
    "\n",
    "使用 **target-decoy 策略**：\n",
    "\n",
    "- 在数据库中加入一份“假的反向或打乱序列”（decoy）；\n",
    "- 把真实（target）和假（decoy）肽段都参与搜索；\n",
    "- 观察 decoy 匹配占比，估算整体的错误识别率。\n",
    "\n",
    "---\n",
    "\n",
    "### 举个例子：\n",
    "\n",
    "- 总共匹配出 1000 条肽段；\n",
    "- 其中 10 条匹配到了 decoy 库；\n",
    "- 则估计有 10 条 target 匹配也是错的 ➜ FDR = 10 / 1000 = **1%**\n",
    "\n",
    "所以：**设置 FDR ≤ 1% 意味着你最多接受 1% 的假阳性结果。**\n",
    "\n",
    "---\n",
    "\n",
    "## 总结表格 | Summary Table\n",
    "\n",
    "| 项目 | 内容（中文） | 内容（English） |\n",
    "|------|--------------|------------------|\n",
    "| 鉴定方法 | 数据库搜索（MS2 vs 理论肽段） | Database search (MS2 vs theoretical peptides) |\n",
    "| 工具 | SEQUEST, Andromeda | SEQUEST, Andromeda |\n",
    "| 数据库 | SwissProt, UniProt | SwissProt, UniProt |\n",
    "| 匹配依据 | b/y 离子的 m/z 与强度 | b/y ion patterns (m/z & intensity) |\n",
    "| FDR 含义 | 假阳性比例 | False discovery rate |\n",
    "| 常用 FDR 阈值 | ≤ 1% | ≤ 1% |\n",
    "\n",
    "---\n",
    "\n",
    "## 延伸阅读 | Further Reading\n",
    "\n",
    "- Elias, J. E., & Gygi, S. P. (2007). *Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry*. Nat. Methods, 4(3), 207–214.  \n",
    "  https://doi.org/10.1038/nmeth1019\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Peptide Identification 中谱图匹配的数学原理\n",
    "\n",
    "---\n",
    "\n",
    "## 1. 问题背景 | Problem Setting\n",
    "\n",
    "在质谱（MS/MS）中，我们的目标是根据实验获得的 MS2 谱图，识别出最可能的肽段序列。  \n",
    "This requires comparing the experimental MS2 spectrum to many theoretical spectra and **scoring their similarity**.\n",
    "\n",
    "---\n",
    "\n",
    "## 2. 向量表示谱图 | Representing Spectra as Vectors\n",
    "\n",
    "我们可以将谱图离散化成向量的形式，令：\n",
    "\n",
    "$$\n",
    "S_{\\text{exp}} = [I_1^{\\text{(exp)}}, I_2^{\\text{(exp)}}, \\ldots, I_n^{\\text{(exp)}}]\n",
    "$$\n",
    "\n",
    "$$\n",
    "S_{\\text{theory}} = [I_1^{\\text{(theory)}}, I_2^{\\text{(theory)}}, \\ldots, I_n^{\\text{(theory)}}]\n",
    "$$\n",
    "\n",
    "其中第 \\( i \\) 个元素表示某个 m/z 区间（bin）上的离子强度。\n",
    "\n",
    "\n",
    "---\n",
    "\n",
    "## 3. 匹配打分方法 | Matching Score Methods\n",
    "\n",
    "### 3.1 Dot Product（向量内积）\n",
    "\n",
    "$$\n",
    "\\text{DotScore} = \\sum_{i=1}^{n} I_i^{\\text{(exp)}} \\cdot I_i^{\\text{(theory)}}\n",
    "$$\n",
    "\n",
    "- 度量两个谱图在每个 m/z 上的强度一致性；\n",
    "- 如果强度在相同位置都很高，则分数高；\n",
    "- 常用于余弦相似度计算（见下）。\n",
    "\n",
    "---\n",
    "\n",
    "### 3.2 Cosine Similarity（余弦相似度）\n",
    "\n",
    "$$\n",
    "\\text{CosineScore} = \\frac{\\sum_{i=1}^{n} I_i^{\\text{(exp)}} \\cdot I_i^{\\text{(theory)}}}{\\sqrt{\\sum_{i=1}^{n} \\left(I_i^{\\text{(exp)}}\\right)^2} \\cdot \\sqrt{\\sum_{i=1}^{n} \\left(I_i^{\\text{(theory)}}\\right)^2}}\n",
    "$$\n",
    "\n",
    "- 归一化后计算两个谱图夹角的余弦；\n",
    "- 接近 1 表示高度相似。\n",
    "\n",
    "---\n",
    "\n",
    "### 3.3 XCorr（交叉相关打分）数学定义\n",
    "\n",
    "XCorr（Cross-correlation score）是 SEQUEST 中用于谱图匹配的鲁棒打分方式，基本思想是：\n",
    "\n",
    "> **将实验谱图与理论谱图对齐后计算匹配强度（RawScore），再减去其“随机错位匹配”的平均强度（ExpectedBackground），提高抗噪性能。**\n",
    "\n",
    "\n",
    "#### 原始匹配得分（Raw Score）\n",
    "\n",
    "$$\n",
    "\\text{RawScore} = \\sum_{k=1}^{n} x_k \\cdot y_k\n",
    "$$\n",
    "\n",
    "- \\( x_k \\)：理论谱图向量中的第 \\( k \\) 个 bin，通常为 0 或 1，表示是否有预测碎片；\n",
    "- \\( y_k \\)：实验谱图向量中的第 \\( k \\) 个 bin 的离子强度。\n",
    "\n",
    "\n",
    "#### 背景期望（Expected Background）\n",
    "\n",
    "为估计“随机匹配”的平均值，SEQUEST 计算错位后的匹配情况：\n",
    "\n",
    "$$\n",
    "\\text{ExpectedBackground} = \\frac{1}{2L + 1} \\sum_{\\delta = -L}^{L} \\sum_{k=1}^{n} x_k \\cdot y_{k + \\delta}, \\quad \\delta \\ne 0\n",
    "$$\n",
    "\n",
    "- \\( \\delta \\)：滑动偏移量（shift），表示谱图错位的程度；\n",
    "- 排除 \\(\\delta = 0\\) 是因为那就是正对齐（RawScore），不能算背景；\n",
    "- 总共用了 \\( 2L \\) 个非中心位置（前 \\( L \\) 个 + 后 \\( L \\) 个）；\n",
    "- **加上中心 \\(\\delta = 0\\)** 一共是 \\( 2L + 1 \\) 项，所以为了取“平均”，分母设为 \\( 2L + 1 \\)。\n",
    "\n",
    "> ⚠️ **注意**：虽然 \\(\\delta = 0\\) 被排除在求和之外，但分母仍设为 \\( 2L + 1 \\)（而不是 \\( 2L \\)），\n",
    "> 这是因为 SEQUEST 设计中为了标准化背景分数，使其能与 RawScore 直接做差时有更平衡的尺度。\n",
    "\n",
    "\n",
    "#### 最终打分公式（XCorr）\n",
    "\n",
    "$$\n",
    "\\text{XCorr} = \\text{RawScore} - \\text{ExpectedBackground}\n",
    "$$\n",
    "\n",
    "- 如果某个肽段的匹配是“真实的”，那么正对齐的得分（RawScore）应远高于随机错位匹配（背景）；\n",
    "- 所以 XCorr 会高；\n",
    "- 如果是随机匹配，RawScore 与背景相似，XCorr 会接近 0。\n",
    "\n",
    "\n",
    "#### 实验谱图预处理（补充）\n",
    "\n",
    "在实际实现中，为了避免强峰主导得分，SEQUEST 会对 \\( y_k \\) 做如下归一化：\n",
    "\n",
    "- 强度归一化（sqrt scaling）：\\( y_k \\leftarrow \\sqrt{y_k} \\)\n",
    "- 或最大值缩放（normalization）：\\( y_k \\leftarrow \\frac{y_k}{\\max(y)} \\)\n",
    "\n",
    "\n",
    "---\n",
    "\n",
    "## 4. 是不是期望？| Is the dot product an expectation?\n",
    "\n",
    "$$\n",
    "\\sum_{i=1}^{n} I_i^{\\text{(exp)}} \\cdot I_i^{\\text{(theory)}}\n",
    "$$\n",
    "\n",
    "这不是统计学意义上的期望（expectation），因为：\n",
    "\n",
    "- 没有概率权重；\n",
    "- 不是对随机变量的加权平均；\n",
    "- 它是 **线性代数中的内积操作**（dot product），衡量谱图向量对齐程度。\n",
    "\n",
    "---\n",
    "\n",
    "## 参考资料 | References\n",
    "\n",
    "- Eng, J. K., McCormack, A. L., & Yates, J. R. (1994). *An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database*. JASMS.\n",
    "- Cox, J., & Mann, M. (2008). *MaxQuant enables high peptide identification rates...*. Nat Biotech.\n",
    "- Frank, A., & Pevzner, P. (2005). *PepNovo: de novo peptide sequencing via probabilistic network modeling*. Anal Chem.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5. 蛋白定量 | Protein Quantification\n",
    "\n",
    "---\n",
    "\n",
    "### Label-Free Quantification (LFQ) 是什么？\n",
    "\n",
    "LFQ 是通过 MS1 色谱峰面积来估算肽段在样本中的丰度：\n",
    "\n",
    "- 对每个肽段，提取其 **XIC（Extracted Ion Chromatogram）**；\n",
    "- 计算保留时间区间内的峰面积；\n",
    "- 面积大小反映该肽段在样本中的丰度（相对量）。\n",
    "\n",
    "---\n",
    "\n",
    "### ✅ 什么能比较？\n",
    "\n",
    "- 同一个肽段，在不同样本之间的强度变化  \n",
    "  ✅ 可以比较，因为它们经历了相同的电离和检测过程\n",
    "\n",
    "- 同一个蛋白的多个肽段，在不同样本中汇总后的平均  \n",
    "  ✅ 通常可以比较（通过多个肽段平均误差）\n",
    "\n",
    "---\n",
    "\n",
    "### ❌ 什么不能直接比较？\n",
    "\n",
    "- 不同肽段之间的强度大小  \n",
    "  ❌ 不可以比较，因为它们的电离效率、色谱行为等不同\n",
    "\n",
    "- 不同蛋白之间的总强度大小  \n",
    "  ❌ 通常不建议比较，除非做过归一化和标准化\n",
    "\n",
    "---\n",
    "\n",
    "### 📉 为什么不同肽段不能直接比较？\n",
    "\n",
    "#### 1. 离子化效率不同（Ionization Efficiency）\n",
    "\n",
    "- 不同肽段带电能力差异大（如含多个 K/R 的更容易电离）；\n",
    "- 即使浓度一样，强度可能差别 10 倍以上。\n",
    "\n",
    "#### 2. 色谱行为不同（Retention Profile）\n",
    "\n",
    "- 峰展宽 vs. 峰集中，面积和峰值关系不同；\n",
    "- 对比瞬时强度易受干扰。\n",
    "\n",
    "#### 3. 仪器响应曲线差异\n",
    "\n",
    "- 不同 m/z 的检测灵敏度略有偏差；\n",
    "- 大肽段或带多电荷的响应可能偏低。\n",
    "\n",
    "---\n",
    "\n",
    "### 📐 数学表达\n",
    "\n",
    "对于肽段 \\( P \\)，在样本 \\( i \\) 中的 MS1 强度记为：\n",
    "\n",
    "$$\n",
    "\\text{Intensity}_{P, i} = k_P \\cdot A_{P, i}\n",
    "$$\n",
    "\n",
    "其中：\n",
    "\n",
    "- \\( A_{P, i} \\)：第 \\( i \\) 个样本中该肽段的实际丰度；\n",
    "- \\( k_P \\)：肽段 \\( P \\) 的电离常数（未知但固定）；\n",
    "\n",
    "因此：\n",
    "\n",
    "- 对于同一肽段比较不同样本：\n",
    "  \n",
    "  $$\n",
    "  \\frac{\\text{Intensity}_{P, i}}{\\text{Intensity}_{P, j}} = \\frac{A_{P, i}}{A_{P, j}} \\quad \\text{（可比较）}\n",
    "  $$\n",
    "\n",
    "- 但对于两个不同肽段 \\( P \\) 和 \\( Q \\)：\n",
    "\n",
    "  $$\n",
    "  \\frac{\\text{Intensity}_{P}}{\\text{Intensity}_{Q}} = \\frac{k_P \\cdot A_P}{k_Q \\cdot A_Q} \\quad \\text{（不可比较）}\n",
    "  $$\n",
    "\n",
    "---\n",
    "\n",
    "### ✅ 总结 | Summary\n",
    "\n",
    "| 比较对象 | 是否推荐？ | 原因 |\n",
    "|-----------|--------------|--------|\n",
    "| 同一肽段在不同样本中的强度 | ✅ 可以 | 电离效率相同，可反映相对丰度 |\n",
    "| 同一蛋白在不同样本中（多个肽段汇总） | ✅ 可以 | 误差可平均 |\n",
    "| 不同肽段之间的强度 | ❌ 不推荐 | 电离行为不同 |\n",
    "| 不同蛋白之间的总强度 | ❌ 不推荐 | 缺乏统一标准，误差大 |\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 什么是 XIC 面积？| What is XIC Area?\n",
    "\n",
    "XIC（Extracted Ion Chromatogram）面积是定量质谱中的关键指标：\n",
    "\n",
    "- 对某个 m/z 匹配的肽段，提取其在 LC-MS 过程中的保留时间窗口；\n",
    "- 在该窗口内记录 MS1 层上的信号强度曲线；\n",
    "- 对该强度曲线积分，得到面积；\n",
    "- 面积越大，说明该肽段在样本中的丰度越高。\n",
    "\n",
    "---\n",
    "\n",
    "### 数学表达 | Mathematical Expression\n",
    "\n",
    "令：\n",
    "\n",
    "- \\( I(t) \\)：在时间 \\( t \\) 上某个 m/z 的 MS1 信号；\n",
    "- \\( t_1, t_2 \\)：肽段色谱峰的开始和结束时间；\n",
    "\n",
    "则 XIC 面积为：\n",
    "\n",
    "$$\n",
    "A = \\int_{t_1}^{t_2} I(t) \\, dt\n",
    "$$\n",
    "\n",
    "在实际采样中，用离散求和近似：\n",
    "\n",
    "$$\n",
    "A \\approx \\sum_{t = t_1}^{t_2} I(t) \\cdot \\Delta t\n",
    "$$\n",
    "\n",
    "---\n",
    "\n",
    "### 说明 | Notes\n",
    "\n",
    "- 面积越大，肽段浓度越高（相对）；\n",
    "- 同一个肽段跨样本比较是可靠的；\n",
    "- 但不同肽段面积不可直接比较（见前节说明）。\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## MS1 信号的函数模型 | Mathematical Shape of MS1 Signal\n",
    "\n",
    "---\n",
    "\n",
    "### 什么是 MS1 信号？\n",
    "\n",
    "MS1 信号指的是在质谱一级（MS1）中，**某个特定 m/z 离子**在随时间变化过程中的信号强度：\n",
    "\n",
    "- 每次 LC-MS 扫描时记录该 m/z 的强度；\n",
    "- 连续扫描获得其随时间的强度变化；\n",
    "- 称为 **XIC（Extracted Ion Chromatogram）** 曲线。\n",
    "\n",
    "---\n",
    "\n",
    "### MS1 信号长什么样？| What Does MS1 Signal Look Like?\n",
    "\n",
    "在色谱过程中，肽段被洗脱出来时会形成一个“峰”：\n",
    "\n",
    "- 通常是近似 **高斯分布（Gaussian peak）**；\n",
    "- 有时存在拖尾（tailing） ➜ 类似于 **偏高斯峰** 或 **EMG（Exponentially Modified Gaussian）**。\n",
    "\n",
    "---\n",
    "\n",
    "### 理想模型：高斯函数 | Ideal Case: Gaussian Function\n",
    "\n",
    "$$\n",
    "I(t) = A \\cdot \\exp\\left( -\\frac{(t - t_r)^2}{2\\sigma^2} \\right)\n",
    "$$\n",
    "\n",
    "- \\( I(t) \\)：保留时间 \\( t \\) 时的 MS1 强度；\n",
    "- \\( A \\)：峰高（最大信号强度）；\n",
    "- \\( t_r \\)：色谱保留时间（肽段流出的中心时间）；\n",
    "- \\( \\sigma \\)：峰宽，决定峰的扩散程度。\n",
    "\n",
    "---\n",
    "\n",
    "### 实际模型：Exponentially Modified Gaussian（EMG）\n",
    "\n",
    "考虑洗脱过程中出现拖尾，实际模型可以使用 EMG 表示：\n",
    "\n",
    "$$\n",
    "I(t) = A \\cdot \\exp\\left( -\\frac{t - t_r}{\\tau} \\right) \\cdot \\Phi\\left( \\frac{t - t_r}{\\sigma} \\right)\n",
    "$$\n",
    "\n",
    "其中：\n",
    "\n",
    "- \\( \\Phi(\\cdot) \\)：标准正态分布的累积分布函数（CDF）；\n",
    "- \\( \\tau \\)：指数衰减项，控制拖尾程度；\n",
    "- 当 \\( \\tau \\to \\infty \\) 时恢复为标准高斯。\n",
    "\n",
    "---\n",
    "\n",
    "### 为什么是峰形？| Why Is It Peak-Shaped?\n",
    "\n",
    "- LC（液相色谱）使肽段按疏水性分离，每种肽段在特定时间洗脱；\n",
    "- 这个时间窗口内，该 m/z 的信号会出现强度上升 → 峰值 → 下降；\n",
    "- MS1 连续采集信号就形成了时间轴上的峰曲线。\n",
    "\n",
    "---\n",
    "\n",
    "### 应用：XIC 面积定量\n",
    "\n",
    "提取该峰区间的积分面积作为相对丰度指标：\n",
    "\n",
    "$$\n",
    "\\text{XIC Area} = \\int_{t_1}^{t_2} I(t) \\, dt \\approx \\sum_{i=1}^{n} I(t_i) \\cdot \\Delta t\n",
    "$$\n",
    "\n",
    "- XIC 面积反映该肽段被检测到的“总量”；\n",
    "- 只在同一个肽段不同样本中具有可比性。\n",
    "\n",
    "---\n",
    "\n",
    "### 总结 | Summary\n",
    "\n",
    "| 属性 | 模型 | 特征 |\n",
    "|------|------|------|\n",
    "| 理想信号 | 高斯函数 | 对称峰 |\n",
    "| 实际信号 | EMG 模型 | 拖尾偏移 |\n",
    "| 用途 | XIC 积分定量 | 面积与丰度相关 |\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5.1 Protein Inference and Grouping（蛋白推断与分组）\n",
    "\n",
    "在质谱分析中，由于一个肽段可能来源于多个蛋白质（例如同源蛋白或剪接变体），我们无法根据“肽段列表”直接唯一对应出具体的蛋白质。\n",
    "\n",
    "**蛋白推断（Protein Inference）** 的目标是：  \n",
    "👉 根据已识别的肽段，确定最有可能存在的蛋白质集合。\n",
    "\n",
    "### 常见策略：最大覆盖原则（Parsimony Principle）\n",
    "- 选择**最小数量的蛋白质集合**，以解释**最多的肽段**。\n",
    "- 这个策略假设样本中存在的是真正“必需”的蛋白质，而不是所有可能解释肽段的蛋白质。\n",
    "\n",
    "### 蛋白质分组（Protein Grouping）\n",
    "- 若多个蛋白质共享相同的肽段，无法区分其来源，则将它们归为**同一个蛋白组**（Protein Group）。\n",
    "- 这样做可以减少冗余，但会降低对同源蛋白或剪接变体的分辨能力。\n",
    "\n",
    "> ⚠️ **注意：**  \n",
    "> 这种分组策略可能影响生物学解释，特别是在分析具有高同源性蛋白家族时。\n",
    "\n",
    "### 最大覆盖原则的数学表达（Set Cover Formulation）\n",
    "\n",
    "设：\n",
    "- $\\mathcal{P} = \\{p_1, p_2, \\dots, p_m\\}$ 为被识别出的肽段集合；\n",
    "- $\\mathcal{G} = \\{G_1, G_2, \\dots, G_n\\}$ 为候选蛋白集合，每个 $G_i \\subseteq \\mathcal{P}$ 表示第 $i$ 个蛋白可产生的肽段集合。\n",
    "\n",
    "目标：\n",
    "- 从 $\\mathcal{G}$ 中选出一个最小子集 $\\mathcal{C} \\subseteq \\mathcal{G}$，使得它们的并集覆盖所有肽段：\n",
    "\n",
    "$$\n",
    "\\bigcup_{G_i \\in \\mathcal{C}} G_i = \\mathcal{P}\n",
    "$$\n",
    "\n",
    "- 并且满足最简原则，即所选蛋白数量最少：\n",
    "\n",
    "$$\n",
    "\\min |\\mathcal{C}|\n",
    "$$\n",
    "\n",
    "这即是经典的集合覆盖问题（Set Cover Problem），是一个 NP-难问题，常用贪心或启发式算法进行近似求解。\n",
    "\n",
    "---\n",
    "\n",
    "## 5.2 Protein-Level FDR Control（蛋白水平的 FDR 控制）\n",
    "\n",
    "在肽段层面控制假阳性不足以保证蛋白层面结果的可靠性。\n",
    "\n",
    "因此，需要在蛋白质推断后，对蛋白识别结果进行 **假发现率（False Discovery Rate, FDR）控制**。\n",
    "\n",
    "### 实施方法：\n",
    "- 构建蛋白质的 Target-Decoy 列表；\n",
    "- 通过**分数排序**，控制识别出的蛋白集合中**假阳性比例不超过指定阈值**（如 1%）。\n",
    "\n",
    "> ✅ 通常与肽段级别的 FDR 控制联合使用，提升整体结果的可信度。\n",
    "\n",
    "### 蛋白水平的 FDR 控制：数学原理\n",
    "\n",
    "在 Target-Decoy 方法中：\n",
    "\n",
    "- $\\mathcal{T}$：被识别的 target 蛋白数量（真实数据库中的蛋白）；\n",
    "- $\\mathcal{D}$：被识别的 decoy 蛋白数量（虚构数据库中的蛋白）；\n",
    "- 所有蛋白按打分（score）从高到低排序，设定一个打分阈值 $s$；\n",
    "- 统计在该阈值 $s$ 以上的 target 和 decoy 数量。\n",
    "\n",
    "定义 FDR（False Discovery Rate）为：\n",
    "\n",
    "$$\n",
    "\\text{FDR}(s) = \\frac{|\\mathcal{D}_s|}{|\\mathcal{T}_s|}\n",
    "$$\n",
    "\n",
    "其中：\n",
    "- $\\mathcal{D}_s = \\{d \\in \\text{decoy proteins} \\mid \\text{score}(d) \\geq s \\}$；\n",
    "- $\\mathcal{T}_s = \\{t \\in \\text{target proteins} \\mid \\text{score}(t) \\geq s \\}$。\n",
    "\n",
    "\n",
    "#### 目标：\n",
    "找到满足 FDR 不超过阈值 $\\alpha$（通常为 0.01）的最大打分阈值 $s^*$：\n",
    "\n",
    "$$\n",
    "s^* = \\max \\left\\{ s \\,\\middle|\\, \\frac{|\\mathcal{D}_s|}{|\\mathcal{T}_s|} \\leq \\alpha \\right\\}\n",
    "$$\n",
    "\n",
    "然后保留所有 $\\text{score} \\geq s^*$ 的蛋白作为最终可信识别结果。\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: pandas in /Users/zixuanye/opt/anaconda3/lib/python3.9/site-packages (1.3.4)\n",
      "Requirement already satisfied: python-dateutil>=2.7.3 in /Users/zixuanye/opt/anaconda3/lib/python3.9/site-packages (from pandas) (2.8.2)\n",
      "Requirement already satisfied: pytz>=2017.3 in /Users/zixuanye/opt/anaconda3/lib/python3.9/site-packages (from pandas) (2021.3)\n",
      "Requirement already satisfied: numpy>=1.17.3 in /Users/zixuanye/opt/anaconda3/lib/python3.9/site-packages (from pandas) (1.22.0)\n",
      "Requirement already satisfied: six>=1.5 in /Users/zixuanye/opt/anaconda3/lib/python3.9/site-packages (from python-dateutil>=2.7.3->pandas) (1.16.0)\n",
      "Score threshold at 1% FDR: 88.53\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 576x360 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "!pip install pandas\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# 模拟数据：1000个 target + 1000个 decoy\n",
    "np.random.seed(42)\n",
    "target_scores = np.random.normal(loc=50, scale=10, size=1000)\n",
    "decoy_scores = np.random.normal(loc=40, scale=10, size=1000)\n",
    "\n",
    "# 构建 DataFrame\n",
    "df = pd.DataFrame({\n",
    "    'score': np.concatenate([target_scores, decoy_scores]),\n",
    "    'type': ['target'] * 1000 + ['decoy'] * 1000\n",
    "})\n",
    "\n",
    "# 按打分从高到低排序\n",
    "df = df.sort_values(by='score', ascending=False).reset_index(drop=True)\n",
    "\n",
    "# 累计 target / decoy 数量\n",
    "df['cum_target'] = (df['type'] == 'target').cumsum()\n",
    "df['cum_decoy'] = (df['type'] == 'decoy').cumsum()\n",
    "\n",
    "# FDR 计算\n",
    "df['FDR'] = df['cum_decoy'] / df['cum_target']\n",
    "\n",
    "# 设定阈值，例如 FDR <= 1%\n",
    "threshold_index = df[df['FDR'] <= 0.01].first_valid_index()\n",
    "score_threshold = df.loc[threshold_index, 'score']\n",
    "print(f\"Score threshold at 1% FDR: {score_threshold:.2f}\")\n",
    "\n",
    "# 可视化\n",
    "plt.figure(figsize=(8, 5))\n",
    "plt.plot(df['score'], df['FDR'], label='FDR curve')\n",
    "plt.axhline(0.01, color='red', linestyle='--', label='1% FDR')\n",
    "plt.axvline(score_threshold, color='green', linestyle='--', label=f'Threshold = {score_threshold:.2f}')\n",
    "plt.xlabel('Score')\n",
    "plt.ylabel('FDR')\n",
    "plt.title('Protein-level FDR vs. Score Threshold')\n",
    "plt.legend()\n",
    "plt.grid(True)\n",
    "plt.tight_layout()\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5.3 Protein Group Quantification（蛋白组的定量）\n",
    "\n",
    "由于蛋白组中包含多个无法区分的蛋白质成员，因此无法对单个蛋白进行精确定量，只能对**整个蛋白组**进行定量。\n",
    "\n",
    "### 常见定量策略：\n",
    "\n",
    "- **唯一肽段（unique peptides）法**：  \n",
    "  仅使用只映射到该蛋白组的肽段进行定量。\n",
    "  \n",
    "- **加权平均法**：  \n",
    "  对多个肽段的定量值进行加权平均（可考虑肽段强度、重复性等因素）。\n",
    "\n",
    "- **共享肽段分配法**：  \n",
    "  利用数学模型将共享肽段信号在可能来源的蛋白中分配。\n",
    "\n",
    "> 🎯 选择不同策略会影响最终定量结果，需根据研究目的权衡。\n",
    "\n",
    "\n",
    "### 5.3 蛋白组定量的数学建模\n",
    "\n",
    "设：\n",
    "- 一个蛋白组包含蛋白 $P_1, P_2, \\dots, P_K$；\n",
    "- 被识别出的肽段集合为 $\\mathcal{P} = \\{p_1, p_2, \\dots, p_n\\}$；\n",
    "- 每个肽段 $p_i$ 的定量强度为 $I_i$，且 $p_i$ 可由蛋白集合 $S_i \\subseteq \\{P_1, \\dots, P_K\\}$ 生成。\n",
    "\n",
    "#### 1. 唯一肽段法（Unique Peptides Only）\n",
    "\n",
    "- 提取 $\\mathcal{U} = \\{p_i \\mid |S_i| = 1 \\}$（只来自一个蛋白组的肽段）；\n",
    "- 定量值为唯一肽段的平均或加权和：\n",
    "\n",
    "$$\n",
    "I_{\\text{protein group}} = \\frac{1}{|\\mathcal{U}|} \\sum_{p_i \\in \\mathcal{U}} I_i\n",
    "\\quad \\text{或} \\quad\n",
    "I_{\\text{weighted}} = \\sum_{p_i \\in \\mathcal{U}} w_i I_i\n",
    "$$\n",
    "\n",
    "其中 $w_i$ 是置信度或重复性相关的权重。\n",
    "\n",
    "\n",
    "#### 2. 加权平均法（Weighted Mean of All Peptides）\n",
    "\n",
    "- 不论肽段是否唯一，全部纳入，按肽段质量、稳定性等赋权：\n",
    "\n",
    "$$\n",
    "I_{\\text{protein group}} = \\sum_{i=1}^{n} w_i I_i\n",
    "\\quad \\text{with} \\quad \\sum w_i = 1\n",
    "$$\n",
    "\n",
    "- 示例：可根据肽段在所有样本中的变异系数（CV）来调整 $w_i$。\n",
    "\n",
    "\n",
    "#### 3. 共享肽段分配法（Shared Peptide Modeling）\n",
    "\n",
    "- 设每个蛋白 $P_j$ 的未知表达强度为 $x_j$；\n",
    "- 肽段强度为这些蛋白的线性组合：\n",
    "\n",
    "$$\n",
    "I_i = \\sum_{j: P_j \\in S_i} x_j\n",
    "$$\n",
    "\n",
    "- 所有肽段形成一个线性方程组：\n",
    "\n",
    "$$\n",
    "\\begin{bmatrix}\n",
    "1 & 1 & 0 \\\\\n",
    "0 & 1 & 1 \\\\\n",
    "1 & 0 & 0 \\\\\n",
    "\\end{bmatrix}\n",
    "\\begin{bmatrix}\n",
    "x_1 \\\\\n",
    "x_2 \\\\\n",
    "x_3 \\\\\n",
    "\\end{bmatrix}\n",
    "=\n",
    "\\begin{bmatrix}\n",
    "I_1 \\\\\n",
    "I_2 \\\\\n",
    "I_3 \\\\\n",
    "\\end{bmatrix}\n",
    "$$\n",
    "\n",
    "- 用最小二乘法或正则化（如 Ridge/Lasso）估计每个蛋白的表达量。\n",
    "\n",
    "\n",
    "#### 共享肽段分配法中的矩阵构造解释\n",
    "\n",
    "我们希望根据肽段与蛋白之间的映射关系，建立线性模型：\n",
    "\n",
    "##### 设定：\n",
    "\n",
    "- 蛋白质：$P_1, P_2, P_3$\n",
    "- 肽段：$p_1, p_2, p_3$\n",
    "- 每个肽段的强度为 $I_1, I_2, I_3$\n",
    "- 每个蛋白的未知表达量为 $x_1, x_2, x_3$\n",
    "\n",
    "##### 假设来源关系如下：\n",
    "\n",
    "- $p_1$ 来源于 $P_1$ 和 $P_2$\n",
    "- $p_2$ 来源于 $P_2$ 和 $P_3$\n",
    "- $p_3$ 来源于 $P_1$\n",
    "\n",
    "##### 则设计矩阵为：\n",
    "\n",
    "$$\n",
    "A =\n",
    "\\begin{bmatrix}\n",
    "1 & 1 & 0 \\\\\n",
    "0 & 1 & 1 \\\\\n",
    "1 & 0 & 0 \\\\\n",
    "\\end{bmatrix}\n",
    "$$\n",
    "\n",
    "对应的线性方程为：\n",
    "\n",
    "$$\n",
    "A \\cdot\n",
    "\\begin{bmatrix}\n",
    "x_1 \\\\\n",
    "x_2 \\\\\n",
    "x_3 \\\\\n",
    "\\end{bmatrix}\n",
    "=\n",
    "\\begin{bmatrix}\n",
    "I_1 \\\\\n",
    "I_2 \\\\\n",
    "I_3 \\\\\n",
    "\\end{bmatrix}\n",
    "$$\n",
    "\n",
    "##### 示例验证：\n",
    "\n",
    "若 $x_1 = 10$, $x_2 = 5$, $x_3 = 8$，则：\n",
    "\n",
    "$$\n",
    "\\begin{aligned}\n",
    "I_1 &= x_1 + x_2 = 15 \\\\\n",
    "I_2 &= x_2 + x_3 = 13 \\\\\n",
    "I_3 &= x_1 = 10\n",
    "\\end{aligned}\n",
    "$$\n",
    "\n",
    "验证：\n",
    "\n",
    "$$\n",
    "A \\cdot \\vec{x} =\n",
    "\\begin{bmatrix}\n",
    "1 & 1 & 0 \\\\\n",
    "0 & 1 & 1 \\\\\n",
    "1 & 0 & 0 \\\\\n",
    "\\end{bmatrix}\n",
    "\\begin{bmatrix}\n",
    "10 \\\\\n",
    "5 \\\\\n",
    "8 \\\\\n",
    "\\end{bmatrix}\n",
    "=\n",
    "\\begin{bmatrix}\n",
    "15 \\\\\n",
    "13 \\\\\n",
    "10 \\\\\n",
    "\\end{bmatrix}\n",
    "$$\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Estimated protein intensities:\n",
      " x1 = 10.00, x2 = 5.00, x3 = 8.00\n"
     ]
    }
   ],
   "source": [
    "import numpy as np\n",
    "from numpy.linalg import lstsq\n",
    "\n",
    "# 构建设计矩阵 A（肽段 × 蛋白）\n",
    "A = np.array([\n",
    "    [1, 1, 0],  # p1 from P1 and P2\n",
    "    [0, 1, 1],  # p2 from P2 and P3\n",
    "    [1, 0, 0]   # p3 from P1\n",
    "])\n",
    "\n",
    "# 肽段观测强度向量（假设实验测到）\n",
    "I = np.array([15, 13, 10])  # I1, I2, I3\n",
    "\n",
    "# 求解未知蛋白表达量 x1, x2, x3\n",
    "x, residuals, rank, s = lstsq(A, I, rcond=None)\n",
    "\n",
    "# 输出结果\n",
    "print(f\"Estimated protein intensities:\\n x1 = {x[0]:.2f}, x2 = {x[1]:.2f}, x3 = {x[2]:.2f}\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5.4 Statistical Analysis and Biological Interpretation（统计分析与生物学解释）\n",
    "\n",
    "蛋白定量结果仅是数据的起点，后续的统计分析与生物学解释才是**揭示机制**的关键。\n",
    "\n",
    "### 分析流程：\n",
    "\n",
    "1. **差异表达分析**  \n",
    "   - 例如使用 t 检验、ANOVA、线性模型（如 limma）；\n",
    "   - 通常需多重假设校正（如 Benjamini-Hochberg）。\n",
    "\n",
    "2. **富集分析（Enrichment Analysis）**  \n",
    "   - 将差异蛋白映射到 GO、KEGG、Reactome 等数据库；\n",
    "   - 鉴定显著富集的功能通路或生物过程。\n",
    "\n",
    "3. **网络分析（Network Analysis）**  \n",
    "   - 构建蛋白质相互作用网络（如 STRING）；\n",
    "   - 分析关键调控节点或模块。\n",
    "\n",
    "> 🧠 生物学解释要结合上下游信息（如转录组、代谢组），避免“只看显著值”的陷阱。"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5.4 Statistical Analysis and Biological Interpretation（数学原理）\n",
    "\n",
    "---\n",
    "\n",
    "### 1. 差异表达分析（Differential Expression Analysis）\n",
    "\n",
    "假设我们比较两个条件组（A vs B），每个样本测得某蛋白的表达值 $x_i$：\n",
    "\n",
    "#### a) **t 检验**：\n",
    "- 检验两个组均值是否显著不同：\n",
    "\n",
    "$$\n",
    "t = \\frac{\\bar{x}_A - \\bar{x}_B}{\\sqrt{\\frac{s_A^2}{n_A} + \\frac{s_B^2}{n_B}}}\n",
    "$$\n",
    "\n",
    "- $p$ 值用于评估差异是否显著。\n",
    "\n",
    "#### b) **多重检验校正（FDR）**：\n",
    "- 使用 Benjamini-Hochberg 方法控制假阳性比例：\n",
    "\n",
    "$$\n",
    "\\text{FDR}(i) = \\frac{p_i \\cdot m}{i}\n",
    "$$\n",
    "\n",
    "其中：\n",
    "- $p_i$ 为第 $i$ 小的原始 $p$ 值；\n",
    "- $m$ 为总检验数量；\n",
    "- 最终选择满足 $\\text{FDR} \\leq \\alpha$（如 0.05）的蛋白。\n",
    "\n",
    "#### 多重检验校正：Benjamini–Hochberg 方法（FDR 控制）\n",
    "\n",
    "在富集分析中，我们通常需要对多个通路或功能进行假设检验，可能涉及成百上千个 $p$ 值。为了避免大量假阳性（False Positives），我们使用 **Benjamini–Hochberg (BH)** 方法来控制假发现率（False Discovery Rate, FDR）。\n",
    "\n",
    "\n",
    "##### 问题背景\n",
    "\n",
    "假设你总共做了 $m$ 个假设检验，得到对应的 $p$ 值为：\n",
    "\n",
    "$$\n",
    "p_1, p_2, \\dots, p_m\n",
    "$$\n",
    "\n",
    "将这些 $p$ 值升序排序，记为：\n",
    "\n",
    "$$\n",
    "p_{(1)} \\leq p_{(2)} \\leq \\dots \\leq p_{(m)}\n",
    "$$\n",
    "\n",
    "\n",
    "##### BH 方法的核心公式\n",
    "\n",
    "对于第 $i$ 个排序的 $p$ 值，Benjamini–Hochberg 方法定义其对应的 FDR 值为：\n",
    "\n",
    "$$\n",
    "\\text{FDR}(i) = \\frac{p_{(i)} \\cdot m}{i}\n",
    "$$\n",
    "\n",
    "\n",
    "##### 如何筛选显著富集的通路？\n",
    "\n",
    "1. 设定允许的 FDR 阈值（例如 $\\alpha = 0.05$）；\n",
    "2. 计算每个 $p_{(i)}$ 对应的 FDR 值；\n",
    "3. 找到最大的 $i^*$，使得：\n",
    "\n",
    "$$\n",
    "\\text{FDR}(i^*) \\leq \\alpha\n",
    "$$\n",
    "\n",
    "4. 保留排名在 $1$ 到 $i^*$ 的所有通路，认为其“显著富集”。\n",
    "\n",
    "##### 示例\n",
    "\n",
    "假设 $m = 5$，有如下排序后的 $p$ 值：\n",
    "\n",
    "| 排名 $i$ | $p_{(i)}$ | FDR 值 $\\dfrac{p_{(i)} \\cdot m}{i}$ |\n",
    "|----------|-----------|------------------------------------|\n",
    "| 1        | 0.001     | $0.001 \\cdot 5 / 1 = 0.005$         |\n",
    "| 2        | 0.004     | $0.004 \\cdot 5 / 2 = 0.01$          |\n",
    "| 3        | 0.020     | $0.020 \\cdot 5 / 3 \\approx 0.033$   |\n",
    "| 4        | 0.030     | $0.030 \\cdot 5 / 4 = 0.0375$        |\n",
    "| 5        | 0.050     | $0.050 \\cdot 5 / 5 = 0.05$          |\n",
    "\n",
    "若设定 $\\alpha = 0.05$，则前 5 个都满足条件，可全部保留为显著富集结果。\n",
    "\n",
    "##### 总结\n",
    "\n",
    "Benjamini–Hochberg 方法控制的是：\n",
    "> 在所有被认为“显著”的检验结果中，最多有 $\\alpha$ 比例是错误发现（假阳性）。\n",
    "\n",
    "这比传统 Bonferroni 校正更灵活，尤其适合生物组学中大规模假设检验的场景。\n",
    "\n",
    "\n",
    "---\n",
    "\n",
    "### 2. 功能富集分析（Enrichment Analysis）\n",
    "\n",
    "设：\n",
    "\n",
    "- $M$：背景蛋白总数；\n",
    "- $K$：某通路中蛋白数量；\n",
    "- $n$：差异蛋白数；\n",
    "- $k$：差异蛋白中落在该通路的数量。\n",
    "\n",
    "使用 **超几何检验** 计算富集概率：\n",
    "\n",
    "$$\n",
    "P(X = k) = \\frac{\\binom{K}{k} \\binom{M - K}{n - k}}{\\binom{M}{n}}\n",
    "$$\n",
    "\n",
    "越小的 $p$ 值表示越显著的富集。\n",
    "\n",
    "### 为什么 “至少这么极端” 的概率小，能说明通路富集？\n",
    "\n",
    "在富集分析中，我们想知道：\n",
    "> 差异蛋白中出现大量某通路蛋白，是巧合吗？还是这个通路真的“活跃”或“被调控”了？\n",
    "\n",
    "#### 🎯 假设检验逻辑（Hypothesis Testing）\n",
    "\n",
    "- **零假设（Null Hypothesis）$H_0$**：\n",
    "  通路中的蛋白在差异表达集中是随机出现的（没有富集）。\n",
    "\n",
    "- **观察数据**：\n",
    "  在 $n$ 个差异蛋白中，有 $k$ 个属于某个包含 $K$ 个蛋白的通路。\n",
    "\n",
    "- **超几何分布建模**：\n",
    "  总体大小 $M$，从中随机抽 $n$ 个，其中通路内有 $K$ 个。\n",
    "\n",
    "$$\n",
    "P(X = k) = \\frac{\\binom{K}{k} \\binom{M - K}{n - k}}{\\binom{M}{n}}\n",
    "$$\n",
    "\n",
    "\n",
    "#### 📉 为什么要看“至少这么极端”（Right-tail）\n",
    "\n",
    "我们不关心恰好抽中 $k$ 个通路蛋白的概率，而关心：\n",
    "\n",
    "> 如果 $H_0$ 成立，抽到 “$k$ 个及以上” 这么多通路蛋白的情况，是不是**极其罕见**？\n",
    "\n",
    "因此计算**右尾累积概率**：\n",
    "\n",
    "$$\n",
    "P(X \\geq k) = \\sum_{i = k}^{\\min(K, n)} P(X = i)\n",
    "$$\n",
    "\n",
    "如果 $P(X \\geq k)$ 很小（如 $< 0.01$），说明：\n",
    "\n",
    "- 抽到 ≥$k$ 个通路蛋白的概率在随机条件下**非常罕见**；\n",
    "- 我们有理由怀疑：这个通路**并不是随机的**，而是**富集了**。\n",
    "\n",
    "\n",
    "#### ✅ 结论总结：\n",
    "\n",
    "- 富集分析就是在问：\n",
    "  > “这些通路蛋白出现在差异集里，是巧合吗？”\n",
    "- 如果“至少这么极端”的概率非常小：\n",
    "\n",
    "$$\n",
    "P(X \\geq k) \\ll 1\n",
    "$$\n",
    "\n",
    "> ➤ 拒绝零假设，认为该通路在当前条件下可能发生了激活、抑制或其他功能调控。\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "P(X ≥ 15) = 3.7509e-07\n",
      "✅ 显著富集：通路可能在实验条件下发生调控\n"
     ]
    }
   ],
   "source": [
    "from scipy.stats import hypergeom\n",
    "\n",
    "# 设置参数：\n",
    "M = 20000   # 背景总蛋白数（universe size）\n",
    "K = 200     # 某通路中蛋白数（该通路含 K 个蛋白）\n",
    "n = 300     # 你的差异蛋白数量\n",
    "k = 15      # 差异蛋白中出现在该通路中的数量\n",
    "\n",
    "# 计算右尾 p 值：至少观察到 k 个通路蛋白的概率\n",
    "# 注意：sf = survival function = P(X >= k)\n",
    "p_value = hypergeom.sf(k - 1, M, K, n)\n",
    "\n",
    "print(f\"P(X ≥ {k}) = {p_value:.4e}\")\n",
    "if p_value < 0.05:\n",
    "    print(\"✅ 显著富集：通路可能在实验条件下发生调控\")\n",
    "else:\n",
    "    print(\"❌ 不显著：无法排除这是随机现象\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "\n",
    "### 3. 网络分析（Network Analysis）\n",
    "\n",
    "#### a) 构建蛋白质相互作用图：\n",
    "\n",
    "- 图 $G = (V, E)$，其中节点 $V$ 为蛋白，边 $E$ 为相互作用；\n",
    "- 权重可为互作置信度、共表达强度等。\n",
    "\n",
    "#### b) 分析策略：\n",
    "\n",
    "- **中心性分析（Centrality）**：识别关键节点\n",
    "  - Degree centrality: $\\deg(v)$\n",
    "  - Betweenness centrality: 跨路径频率\n",
    "- **模块检测（Clustering）**：\n",
    "  - 使用图聚类算法（如 Louvain, MCL）发现功能模块；\n",
    "  - 分析模块中是否富集特定功能或差异蛋白。\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
